RANOZEK

Medicinal product

(Invented) name

RANOZEK

Active substance (s)

Ranolazinas

Strength

375 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB18, Ranolazine

Marketing authorisation holder

UAB Nemuno vaistinė, Lietuva

Date of authorisation

2025-09-01

Date of renewal

Documents

2825_2826_2827_RANOZEK 375mg_500mg_750mg_pailg_atp_tab_PZPL_2025-09-01.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Ranolazinas	375 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118458	104564	1104564	lizdinė plokštelė	N60		Receptinis	LT/L/25/2825/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-09-01	Registruotas